Profit Or Loss [Abstract]

STADA Arzneimittel AG - Filing #6743034

Concept	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31	2020-01-01 to 2020-12-31	2020-01-01 to 2020-12-31	2020-01-01 to 2020-12-31	2020-01-01 to 2020-12-31
Profit or loss [abstract]
Profit (loss) [abstract]
Revenue	—	—	—	3.249.451 EUR	3.010.315 EUR	—	—	—
Cost of sales	—	—	—	1.705.444 EUR	1.510.458 EUR	—	—	—
Gross profit	—	—	—	1.544.007 EUR	1.499.857 EUR	—	—	—
Other income	—	—	—	74,086 EUR	28,790 EUR	—	—	—
Distribution costs	—	—	—	718,590 EUR	651,150 EUR	—	—	—
Administrative expenses	—	—	—	222,329 EUR	231,069 EUR	—	—	—
Other expense, by function	—	—	—	135,676 EUR	238,690 EUR	—	—	—
Profit (loss) from operating activities	—	—	—	454,985 EUR	322,831 EUR	—	—	—
Finance income	—	—	—	1,748 EUR	1,901 EUR	—	—	—
Finance costs	—	—	—	124,627 EUR	104,340 EUR	—	—	—
Share of profit (loss) of associates and joint ventures accounted for using equity method	—	—	—	269,000 EUR	93,000 EUR	—	—	—
Profit (loss) before tax	—	—	—	332,375 EUR	220,492 EUR	—	—	—
Tax expense (income)	—	—	—	68,565 EUR	38,593 EUR	—	—	—
Profit (loss)	16,871 EUR	246,939 EUR	246,939 EUR	263,810 EUR	181,899 EUR	167,314 EUR	14,585 EUR	167,314 EUR
Profit (loss), attributable to [abstract]
Profit (loss), attributable to owners of parent	—	—	—	246,939 EUR	167,314 EUR	—	—	—
Profit (loss), attributable to non-controlling interests	—	—	—	16,871 EUR	14,585 EUR	—	—	—